Asymptomatic Relapsed Multiple Myeloma
Case: 56-Year-Old Man With Asymptomatic Relapsed Multiple Myeloma
History:
September 2018
Age, Disease Burden Are Factors in Early Use of Selinexor in Multiple Myeloma
April 22nd 2024During a Case-Based Roundtable® event, Jonathan L. Kaufman, MD, discussed treatment approaches and the tolerability of a selinexor-containing regimen in a patient with relapsed/refractory multiple myeloma in the first article of a 2-part series.
Read More